AI Article Synopsis
- The study examined the risks of percutaneous coronary intervention (PCI) in different weight categories: non-obese, obese, and morbidly obese patients, finding no significant differences in major adverse cardiovascular or cerebrovascular events among the groups.
- Obese patients were generally younger, more often female and diabetic, and had better renal function than non-obese patients. However, they required higher amounts of contrast and experienced increased radiation exposure during PCI.
- The findings suggest that while PCI is safe for obese and morbidly obese patients in terms of clinical outcomes, the related radiation exposure is higher and warrants the need for strategies to reduce it.
Article Abstract
Background: The risks of percutaneous coronary intervention (PCI) in obese and particularly morbidly obese patients remain uncertain.
Methods: 1082 consecutive patients were categorised as non-obese (NO, body mass index (BMI) <30kg/m, n=688), obese (O, BMI 30-40kg/m, n=354) or morbidly obese (MO, BMI ≥40kg/m, n=40). Demographic and procedural information was collated. Monte Carlo simulations modelled radiation dosimetric data.
Results: Obese and morbidly obese patients were younger (p=0.016), more frequently female (p=0.036), more frequently diabetic (p<0.0001), with better renal function (p<0.0001), and prior PCI (p=0.01). There was no difference in major adverse cardiovascular or cerebrovascular events (MACCE) (NO=1.2%, O=0.8%, MO=2.5%, p=NS), acute kidney injury, bleeding, length of stay, 30-day readmission or 30-day mortality. Obese and morbidly obese patients received increased contrast (NO=180 [150-230]mL, O=190 [160-250]mL, MO=200 [165-225]mL, p=0.016), dose area product (NO=75.56 [50.61-113.69]Gycm, O=116.4 [76.11-157.82]Gycm, MO=125.62 [92.22-158.81]Gycm, p<0.0001), entrance air kerma (NO=1439.42 [977.0-2075.5]mGy, O=2111.63 [1492.0-3011.0]mGy, MO=2376.0 [1700.0-3234.42]mGy, p<0.0001), and peak skin dose (NO=1439.42 [977.0-2075.5], O=2111.63 [1492.0-3011.0], MO=2376.0 [1700.0-3234.42], p<0.0001). Effective radiation dose increased in obese patients (NO=20.9±14.9mSv, O=27.4±17.1mSv, MO=24.1±12.6mSv, p<0.0001 for NO vs O, p=0.449 for NO vs MO).
Conclusions: Percutaneous coronary intervention can be performed in obese and morbidly obese patients without elevated risk for most clinical outcomes. However, radiation increases above levels that could cause both transient and late effects. Strategies should be pursued to minimise radiation dose.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hlc.2017.08.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!